Eshito 5 Tablet contains Escitalopram Oxalate 5 mg, a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing serotonin levels in the brain, thereby helping to improve mood, reduce anxiety, and restore emotional balance. It is commonly prescribed to alleviate symptoms such as persistent sadness, loss of interest, excessive worry, and irritability. Eshito 5 Tablet is typically administered once daily, with or without food, and dosage adjustments may be required based on clinical response and tolerability. Patients should be advised that therapeutic effects may take several weeks to manifest, and abrupt discontinuation should be avoided to prevent withdrawal symptoms. Common adverse effects include nausea, headache, insomnia, dry mouth, and fatigue, while more serious side effects such as serotonin syndrome and suicidal ideation require immediate medical attention. Caution is warranted in patients with a history of bipolar disorder, seizures, or concurrent use of monoamine oxidase inhibitors (MAOIs). Eshito 5 Tablet should be used under strict medical supervision, with regular monitoring for efficacy and safety throughout the treatment course.